Literature DB >> 24120113

Overexpression of microRna-200c in CD44+CD133+ CSCS inhibits the cellular migratory and invasion as well as tumorigenicity in mice.

J Dou1, X F He, W H Cao, F S Zhao, X Y Wang, Y R Liu, J Wang.   

Abstract

Cancer stem cells (CSCs) are believed to be responsible for drug resistance, metastasis of tumors. To investigate the biological characteristics of CD44+CD133+CSCs with over- expressing microRNA-200c (miR-200c), and to provide evidences for miR-200c as a tumor suppressor to treat melanoma. CD44+CD133+CSCs were isolated from the mouse melanoma B16F10 cell line by using immune magnetic activated cell sorting. The lentivirus miR-200c was transduced into the cells, and the effect of miR-200c overexpression on the biological characteristics of B16F10 CD44+ CD133+CSCs was analyzed by a series assays. The stable overexpression of miR-200c in B16F10 CD44+CD133+CSCs obviously resulted in downregulation of zinc-finger E-box binding homeobox 1 expression, reduction of the cell proliferation, colony forming, cell migratory and invasion ability in vitro as well as tumorigenicity in vivo compared with those of the B16F10 cells and B16F10 non-CD44+ CD133+CSCs. These findings suggest that the miR-200c overexpression as a novel strategy to target therapy of melanoma CSCs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24120113

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  7 in total

Review 1.  Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.

Authors:  V Taucher; H Mangge; J Haybaeck
Journal:  Cell Oncol (Dordr)       Date:  2016-04-08       Impact factor: 6.730

Review 2.  MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.

Authors:  Anita Thyagarajan; Ahmed Shaban; Ravi Prakash Sahu
Journal:  J Pharmacol Exp Ther       Date:  2017-10-20       Impact factor: 4.030

3.  The KRAS-variant and its impact on normal breast epithelial cell biology.

Authors:  Song-Yi Jung; Poonam Malhotra; Kiana C Nguyen; David Salzman; Yue Qi; Ethan H Pak; Joshua King; Erina Vlashi; David Ann; Joanne B Weidhaas
Journal:  Cell Death Differ       Date:  2019-04-01       Impact factor: 15.828

Review 4.  Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.

Authors:  Dhiraj Kumar; Mahadeo Gorain; Gautam Kundu; Gopal C Kundu
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

5.  Involvement of MicroRNA-296 in the Inhibitory Effect of Epigallocatechin Gallate against the Migratory Properties of Anoikis-Resistant Nasopharyngeal Carcinoma Cells.

Authors:  Chien-Hung Lin; Hsin-Hui Wang; Tsung-Hsien Chen; Ming-Chang Chiang; Peir-Haur Hung; Yann-Jang Chen
Journal:  Cancers (Basel)       Date:  2020-04-15       Impact factor: 6.639

6.  Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis.

Authors:  Xiaoying Wang; Xiangfeng He; Fengshu Zhao; Jing Wang; Hongyi Zhang; Fangfang Shi; Yunxia Zhang; Kai Cai; Jun Dou
Journal:  J Transl Med       Date:  2014-03-14       Impact factor: 5.531

7.  IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer.

Authors:  Yunxia Zhang; Jing Wang; Di Wu; Miao Li; Fenshu Zhao; Mulan Ren; Yunlong Cai; Jun Dou
Journal:  Onco Targets Ther       Date:  2018-04-10       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.